Finch Therapeutics Group, Inc. 4 SEC Filings

Filed On	Filing
10 Jun 2024	Form 4: Smisek Jeffery A, Director Gave 767 shares as a gift
24 May 2024	Form 4: Smisek Jeffery A, Director Gave 3,750 shares as a gift
29 Mar 2024	Form 4: Smisek Jeffery A, Director Sold 8,242 shares ($21.2K)
27 Nov 2023	Form 4: Smisek Jeffery A, Director Sold 1,470 shares ($5.35K)
09 Jun 2023	Form 4: Blischak Matthew P., Chief Executive Officer Granted 962,899 Stock Option (right to buy)
09 Jun 2023	Form 4: Lange Christian H., Director Granted 10,000 Stock Option (right to buy)
09 Jun 2023	Form 4: Smisek Jeffery A, Director Granted 10,000 Stock Option (right to buy)
09 Jun 2023	Form 4: Haft Nicholas, Director Granted 10,000 Stock Option (right to buy)
09 Jun 2023	Form 4: Ferrante Domenic J, Director Granted 10,000 Stock Option (right to buy)
09 Jun 2023	Form 4: Graf Susan E, Director Granted 10,000 Stock Option (right to buy) · Bought 5,010 shares ($1.35K)
09 Jun 2023	Form 4: Shumway Chris, Director Granted 10,000 Stock Option (right to buy)
23 Feb 2023	Form 4: Blaustein Marc, Chief Operating Officer Sold 4,619 shares ($1.76K)
25 Oct 2022	Form 4: Blaustein Marc, Chief Operating Officer Sold 3,636 shares ($5.05K)
25 Oct 2022	Form 4: Vittiglio Joseph, Chief Business & Legal Officer Sold 3,636 shares ($5.05K)
15 Jun 2022	Form 4: Shumway Chris, Director Granted 44,843 Stock Option (right to buy)
15 Jun 2022	Form 4: Lange Christian H., Director Granted 44,843 Stock Option (right to buy)
15 Jun 2022	Form 4: Blaustein Marc, Chief Operating Officer Received 35,000 shares as a grant or award
15 Jun 2022	Form 4: Hamood Samuel A, Director Granted 44,843 Stock Option (right to buy)
15 Jun 2022	Form 4: Vittiglio Joseph, Chief Business & Legal Officer Received 35,000 shares as a grant or award
15 Jun 2022	Form 4: Ferrante Domenic J, Director Granted 44,843 Stock Option (right to buy)

Comments